Roche Pushes Personalization With $2.4bn Foundation Buy-Out

 
• By Kevin Grogan

By picking up the rest of Foundation Medicine, which is now valued at $5.3bn, the Swiss giant is expanding its leadership in cancer diagnostics, genomics and molecular information for personal medicine.

Workman laying exterior paving stones in a low angle view of his gloved hands fitting a brick into a tight fitting space on a sand foundation.
Laying the foundations for personalized medicine • Source: Shutterstock

More from Deals

More from Business